SANC00496



3β-[(β-D-Glucopyranosyl)oxy]-17α-hydroxy-16β-[(O-(2-O-3,4-dimethoxybenzoyl-β-D-xylopyranosyl)-(1→2)-2-O-acetyl-α-L-arabinopyranosyl)oxy]cholest-5-en-22-one





C54H80O21





1065.2









263570-74-7







[H][C@@]8(O[C@H]7CC[C@@]1(C)C(=CC[C@]2([H])[C@]1([H])CC[C@@]6(C)[C@@]2([H])C[C@H](O[C@]5([H])OC[C@H](O)[C@H](O[C@]3([H])OC[C@@H](O)[C@H](O)[C@H]3OC(=O)c4ccc(OC)c(OC)c4)[C@H]5OC(C)=O)[C@]6(O)[C@H](C)C(=O)CCC(C)C)C7)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O

c1ccccc1
C1=C2CCCCC2C2CCC3CCCC3C2C1
C1=CCCCC1
C1=CCC2CCCCC2C1
C1=C2CCCCC2C2CCC3CC(OC4CCCCO4)CC3C2C1
C1CCOCC1
C1=C2CC(OC3CCCCO3)CCC2C2CCC3CCCC3C2C1
O=C(OC1CCCOC1OC1CCOC(OC2CC3CCC4C5CCC(OC6CCCCO6)CC5=CCC4C3C2)C1)c1ccccc1
C1=C2CC(OC3CCCCO3)CCC2C2CCC3CC(OC4CCCCO4)CC3C2C1
C1CCCCC1
O=C(OC1CCCOC1OC1CCOC(OC2CC3CCC4C5CCCCC5=CCC4C3C2)C1)c1ccccc1
C1=C2CCCCC2C2CCC3CC(OC4CC(OC5CCCCO5)CCO4)CC3C2C1
C1=C2CCCCC2CCC1
C1=C2CC(OC3CCCCO3)CCC2C2CCC3CC(OC4CC(OC5CCCCO5)CCO4)CC3C2C1





  • Cholestane

  • Glycoside

  • Steroids and steroid derivatives (Classyfire)


  • Cholest-5-En-22-One, 16-[[2-O-Acetyl-3-O-[2-O-(3,4-Dimethoxybenzoyl)-[Beta]-D-Xylopyranosyl]-[Alpha]-L-Arabinopyranosyl]Oxy]-3-([Beta]-D-Glucopyranosyloxy)-17-Hydroxy-, (3[Beta],16[Beta])-
  • 3[Beta]-[([Beta]-D-Glucopyranosyl)Oxy]-17[Alpha]-Hydroxy-16[Beta]-[(O-(2-O-3,4-Dimethoxybenzoyl-[Beta]-D-Xylopyranosyl)-(1[To]2)-2-O-Acetyl-[Alpha]-L-Arabinopyranosyl)Oxy]Cholest-5-En-22-One
  • 3[Beta]-[([Beta]-D-Glucopyranosyl)Oxy]-17[Alpha]-Hydroxy-16[Beta]-[(O-(2-O-3,4-Dimethoxybenzoyl-[Beta]-D-Xylopyranosyl)-(1[To]2)-2-Oacetyl-[Alpha]-L-Arabinopyranosyl)Oxy]Cholest-5-En-22-One


  • Galtonia candicans

  • Cytotoxic activity on HL-60 leukemia cells